Atlas Trials

A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps

Clinical trial NCT06516302 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06516302
Sponsor
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Rhinosinusitis With Nasal Polyps
Start date
2024-09-19
Primary completion
2026-03-01
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.